Theranexus
Clinical-stage biopharmaceutical company developing treatments for rare neurological disorders.
ALTHX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013286259
- LEI:
- 969500BFCV6IC7MFQP20
- Country:
- France
- Address:
- 60 AVENUE ROCKEFELLER, 69008 LYON
- Website:
- https://www.theranexus.com/en/
- Sector:
- Manufacturing
Description
THX Pharma (formerly Theranexus) is an innovative, clinical-stage biopharmaceutical company that emerged from the French Alternative Energies and Atomic Energy Commission (CEA). The company specializes in developing treatments for rare neurological disorders. It leverages a unique platform for the identification and characterization of advanced therapy drug candidates. Its lead program is a drug candidate in clinical development for Batten disease, a rare neurodegenerative disorder.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-08-11 18:00 |
THERANEXUS ET LA FONDATION BBDF OBTIENNENT LE STATUT DE ' MÉDICAMENT ORPHELIN (…
|
French | 351.3 KB | ||
| 2020-08-11 18:00 |
THERANEXUS AND BBDF OBTAIN ORPHAN DRUG DESIGNATION (ODD) AND RARE PEDIATRIC DIS…
|
English | 389.7 KB | ||
| 2020-08-06 18:00 |
DECLARATION OF TOTAL NUMBER OF SHARES AND VOTING RIGHTS
|
English | 247.2 KB | ||
| 2020-08-06 18:00 |
INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS COMPOSANT L…
|
French | 251.6 KB | ||
| 2020-07-30 08:00 |
THERANEXUS TO PRESENT THE RESULTS OF THN102 FOR PARKINSON'S DISEASE AT THE 2020…
|
English | 642.9 KB | ||
| 2020-07-30 08:00 |
THERANEXUS PRÉSENTERA LES RÉSULTATS DE THN102 DANS LA MALADIE DE PARKINSON A L'…
|
French | 649.8 KB | ||
| 2020-07-20 08:30 |
BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE - 1er SEMESTRE 2020
|
French | 445.0 KB | ||
| 2020-07-09 08:30 |
THERANEXUS ANNOUNCES ITS CASH POSITION AS OF 30 JUNE 2020 AND IMPLEMENTATION OF…
|
English | 488.4 KB | ||
| 2020-07-09 08:30 |
THERANEXUS ANNONCE SA POSITION DE TRÉSORERIE AU 30 JUIN 2020 ET LA MISE EN PLAC…
|
French | 685.8 KB | ||
| 2020-06-24 18:00 |
THERANEXUS OBTIENT UN FINANCEMENT NON DILUTIF DE 3,4 M EUR SOUS FORME DE PRÊT G…
|
French | 474.3 KB | ||
| 2020-06-24 18:00 |
THERANEXUS SECURES EUR 3.4 M LOAN UNDER THE FRENCH STATE GUARANTEE SCHEME (PGE)…
|
English | 587.4 KB | ||
| 2020-02-04 18:00 |
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D'ACTIONS C…
|
French | 278.8 KB | ||
| 2020-02-04 18:00 |
DECLARATION OF TOTAL NUMBER OF SHARES AND VOTING RIGHTS
|
English | 268.5 KB | ||
| 2020-01-27 18:00 |
THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 31 DÉCEMBRE 2019
|
French | 256.9 KB | ||
| 2020-01-27 18:00 |
THERANEXUS REPORTS CASH POSITION AS OF DECEMBER 31, 2019
|
English | 220.2 KB |
Automate Your Workflow. Get a real-time feed of all Theranexus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Theranexus
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Theranexus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
